Dr. R. Michael Tuttle, Chief of Endocrinology Service at Memorial Sloan Kettering Cancer Center in New York City, provides an overview of
how thyroid cancer is staged and
how staging helps guide care.
He discusses how staging helps doctors estimate the likelihood of thyroid cancer affecting a person's lifespan or returning after treatment
(recurrence).
Doctors consider factors such as
age,
tumor size,
the
specific type of thyroid cancer, and
molecular testing. Dr. Tuttle explains that by examining thyroid tissue under a microscope
(histology) helps confirm whether cancer is present and can identify the specific type. Together, he says this information helps doctors estimate individual risk, guide treatment decisions, and develop a personalized follow-up plan.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about thyroid cancer which will help other patients, caregivers, and families.